Citigroup’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1 | Sell |
|
|||||
|
2025
Q2 | $235 | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $9K | Sell |
|
|||||
|
2021
Q4 | $40K | Buy |
|
|||||
|
2021
Q3 | $58K | Sell |
|
|||||
|
2021
Q2 | $133K | Sell |
|
|||||
|
2021
Q1 | $1.56M | Buy |
|
|||||
|
2020
Q4 | $259K | Buy |
|
|||||
|
2020
Q3 | $208K | Sell |
|
|||||
|
2020
Q2 | $357K | Sell |
|
|||||
|
2020
Q1 | $371K | Buy |
|
|||||
|
2019
Q4 | $649K | Buy |
|
|||||
|
2019
Q3 | $624K | Buy |
|
|||||
|
2019
Q2 | $98K | Sell |
|
|||||
|
2019
Q1 | $202K | Buy |
|
|||||
|
2018
Q4 | $150K | Buy |
|
|||||
|
2018
Q3 | $53K | Sell |
|
|||||
|
2018
Q2 | $150K | Buy |
|
|||||
|
2018
Q1 | $90K | Sell |
|
|||||
|
2017
Q4 | $121K | Buy |
|
|||||
|
2017
Q3 | $18K | Sell |
|
|||||
|
2017
Q2 | $41K | Sell |
|
|||||
|
2017
Q1 | $770K | Sell |
|
|||||
|
2016
Q4 | $1.17M | Buy |
|
|||||
|
2016
Q3 | $140K | Sell |
|
|||||
|
2016
Q2 | $209K | Sell |
|
|||||
|
2016
Q1 | $767K | Buy |
|
|||||
|
2015
Q4 | $413K | Buy |
|
|||||
|
2015
Q3 | $6K | Sell |
|
|||||
|
2015
Q2 | $21K | Sell |
|
|||||
|
2015
Q1 | $43K | Sell |
|
|||||
|
2014
Q4 | $90K | Buy |
|
|||||
|
2014
Q3 | $17K | Buy |
|
|||||
|
2014
Q2 | $4K | Sell |
|
|||||
|
2014
Q1 | $92K | Sell |
|
|||||
|
2013
Q4 | $217K | Buy |
|
|||||
|
2013
Q3 | $0 | Sell |
|
|||||
|
2013
Q2 | $201K | Buy |
|